- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02848014
The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor
April 4, 2017 updated by: Winfried Rief, Philipps University Marburg Medical Center
The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor on Subjective and Objective Stress Paramaters
The purpose of the study is to determine whether a short psychological intervention aiming at optimizing expectations is able to foster positive emotions and whether an intervention inducing positive emotions is able improve participants' expectations.
Furthermore, the investigators will examine whether both interventions are effective in buffering the stress response after an acute stressor in a healthy sample compared to a control condition.
Study Overview
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Marburg, Hessen, Germany, 35032
- Department of Psychology, Philipps University Marburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- fluent in German language
Exclusion Criteria:
- chronic disease
- mental disease
- the evening before the day of the experiment until end of the experiment (the next day): caffeine, alcohol, intensive physical exercise, chewing gum
- acute hay fever
- current intake of psychotropic medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Expectation
Participants are asked to think and write about ways how they can positively influence/control the stress during stress induction.
They also can think of strategies they used in their past.
The purpose of this arm is to improve participants' personal control expectations.
|
|
|
Experimental: Emotion
Participants in this group are asked to write a gratitude-letter to a person they want to thank.
The purpose of this arm is to foster positive emotions.
|
|
|
Active Comparator: Control
Participants in this group are asked to do a neutral writing task.
The task is to write a protocol of yesterday's to-dos.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in personal control expectation (Item of the Brief IPQ)
Time Frame: Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1)
|
Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in emotions (PANAS)
Time Frame: Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1)
|
Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1)
|
|
|
Subjective stress ratings
Time Frame: directly after completing the stress induction (approximately 50 minutes after baseline assessment; T2)
|
Questionnaire items
|
directly after completing the stress induction (approximately 50 minutes after baseline assessment; T2)
|
|
Change in Cortisol levels (saliva sample)
Time Frame: Pre-intervention (baseline; T0) vs.Post-intervention (25 minutes after baseline assessment; T1), directly (T2), 15 min (T3) and 30 min (T4) after stress induction
|
directly (T2), 15 min (T3) and 30 min (T4) after stress induction = 50 min, 65 min and 80 min after baseline assessment
|
Pre-intervention (baseline; T0) vs.Post-intervention (25 minutes after baseline assessment; T1), directly (T2), 15 min (T3) and 30 min (T4) after stress induction
|
|
Change in Alpha-Amylase levels (saliva sample)
Time Frame: Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1), directly (T2), 15 min (T3) and 30 min (T4) after stress induction
|
directly (T2), 15 min (T3) and 30 min (T4) after stress induction = 50 min, 65 min and 80 min after baseline assessment
|
Pre-intervention (baseline; T0) vs. Post-intervention (25 minutes after baseline assessment; T1), directly (T2), 15 min (T3) and 30 min (T4) after stress induction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Winfried Rief, Professor, Philipps University Marburg Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
November 30, 2016
Study Registration Dates
First Submitted
June 29, 2016
First Submitted That Met QC Criteria
July 25, 2016
First Posted (Estimate)
July 28, 2016
Study Record Updates
Last Update Posted (Actual)
April 6, 2017
Last Update Submitted That Met QC Criteria
April 4, 2017
Last Verified
June 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 2016-08k
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.